Yarynich K. The combined treatment of ascitic form of ovarian cancer III - IV stage

Object of research - a tratment of ascites ovarian cancer stage III - IV. A research objective: to improve the immediate and long-term results of combined treatment of patients with ovarian cancer ascites stage III - IV by optimizing current treatments. Research methods - clinical, instrumental, laboratory, statistical processing of results. Novelty: the first time a relationship cure for ovarian cancer of immune status in the test suppress leukocyte adhesion. Proven effectiveness of the combined method of treatment, which includes palliative cytoreductive surgery in patients with ascites of ovarian cancer stage III - IV. Results: The advantages of the combined treatment of patients with ascites of ovarian cancer stage III - IV, compared to self-endolymphatic chemotherapy, due to the surgical component of treatment. The median survival in patients who received combination therapy, two times more than those who received a separate endolymphatic polychemotherapy (17.0 vs. 8.8 months., Respectively). Introduced in clinical practice communal health care setting "Donetsk Regional Antitumor Center"; urban inter-Oncology Center of Mariupol, KLPU "City Oncology Center Gorlovka." The results are used for educational Donetsk National Medical University. Gorky. Area of application: medicine (oncology).